Champions Oncology, Inc. CSBR
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.58% | 63.65% | -107.54% | -63.32% | -135.49% |
| Total Depreciation and Amortization | -12.29% | -18.53% | -14.32% | -10.53% | -20.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.52% | 30.58% | 68.29% | 587.23% | 6.93% |
| Change in Net Operating Assets | -814.07% | -131.22% | 55.14% | -99.80% | 110.33% |
| Cash from Operations | -182.00% | -129.09% | -373.27% | -513.07% | 92.93% |
| Capital Expenditure | -19.57% | 5.53% | 11.90% | -157.45% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.57% | 5.93% | 66.67% | -157.45% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 50.00% | 50.00% | -2.63% | -5.41% | -2.70% |
| Issuance of Common Stock | 116.67% | -100.00% | -92.11% | -25.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 335.71% | 40.63% | -- | -29.71% | 62.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.19% | -134.25% | -410.04% | -1,210.87% | 97.08% |